INR 208.18
(-2.19%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 214.04 Million INR | -36.83% |
2022 | 338.85 Million INR | 41.26% |
2021 | 239.87 Million INR | 27.68% |
2020 | 187.86 Million INR | 153.78% |
2019 | 74.02 Million INR | -11.02% |
2018 | 83.19 Million INR | 174.77% |
2017 | -111.26 Million INR | -177.29% |
2016 | 143.96 Million INR | 253.28% |
2015 | 40.75 Million INR | 143.78% |
2014 | 16.71 Million INR | -33.92% |
2013 | 25.29 Million INR | 12.68% |
2012 | 22.45 Million INR | -77.02% |
2011 | 97.68 Million INR | 5.4% |
2010 | 92.68 Million INR | -11.73% |
2009 | 105 Million INR | 6.08% |
2008 | 98.98 Million INR | 90.65% |
2007 | 51.91 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 91.66 Million INR | 304.5% |
2024 Q2 | 139.44 Million INR | 52.13% |
2023 Q3 | 55.05 Million INR | -45.94% |
2023 FY | 214.04 Million INR | -36.83% |
2023 Q1 | 82.44 Million INR | 6.19% |
2023 Q4 | 22.66 Million INR | -58.84% |
2023 Q2 | 101.84 Million INR | 23.53% |
2022 Q3 | 100.44 Million INR | -27.31% |
2022 FY | 338.85 Million INR | 41.26% |
2022 Q4 | 77.63 Million INR | -22.71% |
2022 Q2 | 138.19 Million INR | 122.0% |
2022 Q1 | 62.24 Million INR | 2185.39% |
2021 Q4 | -2.98 Million INR | -105.7% |
2021 Q1 | 89.91 Million INR | 59.23% |
2021 Q2 | 100.53 Million INR | 11.81% |
2021 Q3 | 52.41 Million INR | -47.87% |
2021 FY | 239.87 Million INR | 27.68% |
2020 Q3 | 62.08 Million INR | 36.16% |
2020 FY | 187.86 Million INR | 153.78% |
2020 Q1 | 23.71 Million INR | 85.25% |
2020 Q2 | 45.59 Million INR | 92.25% |
2020 Q4 | 56.46 Million INR | -9.05% |
2019 Q1 | 19.51 Million INR | -40.2% |
2019 Q4 | 12.8 Million INR | -44.44% |
2019 FY | 74.02 Million INR | -11.02% |
2019 Q3 | 23.04 Million INR | 2.85% |
2019 Q2 | 22.4 Million INR | 14.84% |
2018 Q2 | 24.09 Million INR | 142.92% |
2018 Q4 | 32.62 Million INR | 65.63% |
2018 Q3 | 19.69 Million INR | -18.25% |
2018 FY | 83.19 Million INR | 174.77% |
2018 Q1 | 9.92 Million INR | 188.9% |
2017 Q4 | -11.15 Million INR | 51.33% |
2017 FY | -111.26 Million INR | -177.29% |
2017 Q3 | -22.92 Million INR | 41.88% |
2017 Q2 | -39.44 Million INR | -193.46% |
2017 Q1 | 42.2 Million INR | 4233.37% |
2016 Q1 | 8.01 Million INR | -66.01% |
2016 Q3 | 128.68 Million INR | 1944.86% |
2016 Q4 | 974 Thousand INR | -99.24% |
2016 FY | 143.96 Million INR | 253.28% |
2016 Q2 | 6.29 Million INR | -21.5% |
2015 Q3 | 4.86 Million INR | -18.59% |
2015 Q4 | 23.58 Million INR | 384.95% |
2015 FY | 40.75 Million INR | 143.78% |
2015 Q1 | 6.32 Million INR | 1028.78% |
2015 Q2 | 5.97 Million INR | -5.53% |
2014 Q3 | 328 Thousand INR | -95.29% |
2014 FY | 16.71 Million INR | -33.92% |
2014 Q1 | 10.09 Million INR | -19.4% |
2014 Q2 | 6.97 Million INR | -30.97% |
2014 Q4 | -681 Thousand INR | -307.62% |
2013 Q1 | 86 Thousand INR | 104.12% |
2013 FY | 25.29 Million INR | 12.68% |
2013 Q4 | 12.52 Million INR | 6.71% |
2013 Q3 | 11.74 Million INR | 1124.19% |
2013 Q2 | 959 Thousand INR | 1015.12% |
2012 Q3 | 15.54 Million INR | 107.37% |
2012 Q2 | 7.49 Million INR | 397.61% |
2012 Q1 | 1.5 Million INR | -88.14% |
2012 FY | 22.45 Million INR | -77.02% |
2012 Q4 | -2.08 Million INR | -113.44% |
2011 Q2 | 32.7 Million INR | 0.0% |
2011 FY | 97.68 Million INR | 5.4% |
2011 Q4 | 12.69 Million INR | -60.0% |
2011 Q3 | 31.74 Million INR | -2.92% |
2010 FY | 92.68 Million INR | -11.73% |
2009 FY | 105 Million INR | 6.08% |
2008 FY | 98.98 Million INR | 90.65% |
2007 FY | 51.91 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -7461.044% |
Aarti Drugs Limited | 7.14 Billion INR | 97.006% |
Aarti Pharmalabs Limited | 3.12 Billion INR | 93.158% |
Ajanta Pharma Limited | 19.67 Billion INR | 98.912% |
Alembic Limited | 767.77 Million INR | 72.122% |
Alkem Laboratories Limited | 19.46 Billion INR | 98.9% |
Alembic Pharmaceuticals Limited | 5.75 Billion INR | 96.283% |
AstraZeneca Pharma India Limited | 4.47 Billion INR | 95.216% |
Bal Pharma Limited | 214.56 Million INR | 0.247% |
Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -936.212% |
Bliss GVS Pharma Limited | 1.23 Billion INR | 82.613% |
Brooks Laboratories Limited | -72.25 Million INR | 396.241% |
Bafna Pharmaceuticals Limited | 237.66 Million INR | 9.939% |
Caplin Point Laboratories Limited | 7.22 Billion INR | 97.038% |
Divi's Laboratories Limited | 18.31 Billion INR | 98.831% |
Eris Lifesciences Limited | 5.18 Billion INR | 95.869% |
Granules India Limited | 6.52 Billion INR | 96.721% |
Ind-Swift Limited | 1.22 Billion INR | 82.541% |
J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 97.162% |
Jubilant Pharmova Limited | 5.18 Billion INR | 95.875% |
Kilitch Drugs (India) Limited | 208.05 Million INR | -2.879% |
Medicamen Biotech Limited | - INR | -Infinity% |
Medico Remedies Limited | 277.11 Million INR | 22.762% |
Wockhardt Limited | 140 Million INR | -52.886% |
Orchid Pharma Limited | 2.36 Billion INR | 90.935% |
RPG Life Sciences Limited | 2.29 Billion INR | 90.663% |
Shilpa Medicare Limited | 3.76 Billion INR | 94.31% |
Sigachi Industries Limited | 1.47 Billion INR | 85.478% |
Solara Active Pharma Sciences Limited | -3.85 Billion INR | 105.555% |
Unichem Laboratories Limited | - INR | -Infinity% |
Vaishali Pharma Limited | 6.29 Million INR | -3300.699% |
Wanbury Limited | 1.7 Billion INR | 87.463% |
Zydus Lifesciences Limited | 45.39 Billion INR | 99.528% |
FDC Limited | 3.03 Billion INR | 92.945% |
Amrutanjan Health Care Limited | 621.02 Million INR | 65.535% |
Bajaj HealthCare Limited | - INR | -Infinity% |
Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.684% |
Glenmark Life Sciences Limited | 8.97 Billion INR | 97.616% |
Ind-Swift Laboratories Limited | 2 Billion INR | 89.346% |
Laurus Labs Limited | 3.94 Billion INR | 94.579% |
Mangalam Drugs & Organics Limited | 27.45 Million INR | -679.518% |
Nectar Lifesciences Limited | 3.89 Billion INR | 94.499% |
Par Drugs and Chemicals Limited | 551.58 Million INR | 61.196% |
Hester Biosciences Limited | 364.77 Million INR | 41.322% |
Ipca Laboratories Limited | 29.59 Billion INR | 99.277% |
Venus Remedies Limited | 534.65 Million INR | 59.966% |
ZIM Laboratories Limited | 1.09 Billion INR | 80.508% |
Aurobindo Pharma Limited | 104.5 Billion INR | 99.795% |
Morepen Laboratories Limited | 4.17 Billion INR | 94.872% |
Neuland Laboratories Limited | 5.31 Billion INR | 95.975% |
Sequent Scientific Limited | - INR | -Infinity% |
Suven Pharmaceuticals Limited | 4.6 Billion INR | 95.355% |
Valiant Laboratories Limited | - INR | -Infinity% |
Windlas Biotech Limited | 1.29 Billion INR | 83.521% |
Hikal Limited | 1.49 Billion INR | 85.675% |
Innova Captab Limited | 2.53 Billion INR | 91.551% |
Procter & Gamble Health Limited | 2.78 Billion INR | 92.317% |
Themis Medicare Limited | 1.3 Billion INR | 83.575% |
IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 95.669% |
Mankind Pharma Limited | 40.86 Billion INR | 99.476% |
Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 96.708% |
Sakar Healthcare Limited | 495.5 Million INR | 56.804% |
Albert David Limited | 1.33 Billion INR | 83.961% |
Lupin Limited | 27.75 Billion INR | 99.229% |
Gufic Biosciences Limited | 2.89 Billion INR | 92.604% |
Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.795% |
Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 88.772% |
Syncom Formulations (India) Limited | 249.25 Million INR | 14.127% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 25.33 Billion INR | 99.155% |
NATCO Pharma Limited | 25.96 Billion INR | 99.176% |
Suven Life Sciences Limited | -1.22 Billion INR | 117.461% |
Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
Strides Pharma Science Limited | 5.22 Billion INR | 95.904% |
Indoco Remedies Limited | 1.52 Billion INR | 85.959% |
Alpa Laboratories Limited | 61.51 Million INR | -247.948% |
Lasa Supergenerics Limited | -458 Million INR | 146.733% |
Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 105.201% |